Intellectual Property Law

HB Ad Slot
HB Mobile Ad Slot

Intellectual property applies to many different areas of the legal world. Applying for patents for work-products, by individual employees, trademark laws, copyrights, and how companies leverage their IP asset-rights over employees, are just a few of the many areas the National Law Review covers as it pertains to IP.

Intellectual Property Litigation

Intellectual Property disputes are a complex area of law, often involving deep dives into complex concepts to understand the issues at play. In the United States, the United States Patent and Trademark Office (USPTO/PTO) is the agency involved in registering patents and trademarks.   As part of the USPTO, the Patent Trial and Appeal Board settles patent disputes, using a variety of mechanisms to settle issues related to intellectual property.    Some of the mechanisms include inter partes review, post-grant procedures, and covered business method patent reviews.  Issues related to the America Invents Act are also settled through the PTAB. The National Law Review covers changes to standards held by the USPTO in litigation and other patent issues.  The Trademark Trial and Appeal Board settles disputes related to trademarks, such as an ex parte appeal from the denial of an application for registration by an examining attorney, and an inter partes opposition, cancellation, concurrent use, or interference proceeding.  Other agencies involved in patent disputes are the International Trade Commission (ITC) or the Federal Trade Commission (FTC).  The National Law Review covers patent news as it relates to Supreme Court (SCOTUS) and federal circuit courts’ appeals, as well as general patent litigation and new patent filings.

Intellectual Property in Drug Patents

Legal analysis related to drug patents and pharmaceuticals and the interplay with intellectual property issues are also covered by the National Law Review.   Drug patents, biosimilars, generic top-level domain registration (gTLD), trade secrets, non-compete clauses, and other patent application news are updated on the site regularly. Additionally, tangential issues that impact pharmaceutical companies, such as innovator liability and related litigation, are also analyzed by the legal experts who write for the National Law Review. 

Intellectual Property in an Employment Context

The National Law Review has legal analysis on the intersection between intellectual property rights and employment, and who owns ideas, the Work Made For Hire principle as well resulting litigation. Additionally, legislation such as the Defense of Trade Secrets Act and its impact on workplaces, and ongoing litigation related to the legislation is also covered.

International Intellectual Property

Visitors to the site will oftentimes read about international news as it relates to patent applications in the US, and internationally as well. Pharmaceutical patents in Brazil, medical device patent applications from the United Kingdom, or litigation from the European Union, China, India, and other international sectors, are often covered online. Visitors will find the latest coverage, news, and insights on patent applications and litigation, when visiting the National Law Review, for up-to-date practice-area news.

National Law Review Intellectual Property/Patent Law TwitterFor hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Recent Intellectual Property, Patent, Trademark & Copyright News

Title
Custom text Organization Sort descending
May
8
2018
Federal Circuit Finds ANDA Jurisdiction Before PIV Certification Foley & Lardner LLP
Jun
14
2018
Proposed Legislation Would Require Choice Between ANDA Litigation Or AIA Challenges Foley & Lardner LLP
Jun
26
2018
Federal Circuit Chastises PTAB Over Moving Target On Ex Parte Appeal Foley & Lardner LLP
Mar
28
2023
Structuring IP Licenses to Manage Supply Chain Risks in the Automotive Industry Foley & Lardner LLP
Oct
19
2018
Diagnostic Method Claims And Primer Tools Lack Patent- Eligibility Foley & Lardner LLP
Jun
13
2023
Supreme Court’s Jack Daniel’s Decision Clarifies First Amendment Parody Defense in Trademark Infringement Cases Foley & Lardner LLP
Dec
22
2015
Delicious Look At Cookie Press Patent Foley & Lardner LLP
Jan
4
2016
Did PTAB Dose AIA Poison Pill Incorrectly Against Premium Genetics? Foley & Lardner LLP
Jan
15
2016
Denying Prior Art Status In PTAB Proceedings: Petitioner's Failure to Show Section 112 Support in Priority Applications May Be Fatal Foley & Lardner LLP
Jan
26
2016
Incomplete Restriction Requirement Stops Clock For Patent Term Adjustment Foley & Lardner LLP
May
20
2019
Federal Circuit Invalidates Patented Cancer Therapy Foley & Lardner LLP
Nov
27
2023
FTC Weighs in on Threats to Competition from Artificial Intelligence in Comment to U.S. Copyright Office Foley & Lardner LLP
Jan
3
2024
Startup Advisors: What is SAFE? [VIDEO] Foley & Lardner LLP
Aug
13
2019
Federal Circuit Agrees Genotyping Method Is Not Eligible For Patenting Foley & Lardner LLP
Mar
31
2016
USPTO Releases New Rules For AIA Post-Grant Proceedings Foley & Lardner LLP
Feb
29
2024
Generative AI Systems Tee Up Fair Use Fight Foley & Lardner LLP
May
12
2016
New USPTO Guidance On Patent Eligibility Of Natural Products Foley & Lardner LLP
Feb
12
2020
Automotive & Manufacturing MarketTrends | February 2020, Issue 4 Foley & Lardner LLP
May
31
2016
On Sale Bar Invalidates Safyral, Beyaz Folate Patent Foley & Lardner LLP
Feb
18
2020
Trade Secret Ruling Is a Head Scratcher Foley & Lardner LLP
Jun
22
2016
Impact of UK's Brexit for Intellectual Property Rights Foley & Lardner LLP
Jul
6
2016
Federal Circuit's Primer on Patent-Eligibility in Rapid Litig. v. CellzDirect Foley & Lardner LLP
Jul
29
2016
CRISPR Update – July 2016 Foley & Lardner LLP
May
5
2020
USPTO Extends CARES Act Deadline Relief Foley & Lardner LLP
Aug
25
2016
The Evolving Standard for Pleading Direct Patent Infringement Foley & Lardner LLP
Aug
30
2016
Estoppel Prevents Second IPR Petition Even When New References Were Missed By First Search Foley & Lardner LLP
Sep
15
2016
Apotex Biosimilar Cleared Of Infringement But Pre-Marketing Notice Still Required Foley & Lardner LLP
Sep
21
2016
Inherent Disclosure Satisfied Written Description Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins